Clinical Trial Update: Ribavirin, Its Dosing Regime [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on ribavirin dosing regime for Hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED